Obstetrics & Gynecology Doctors in Albert Lea, MN Accepting Medicare

5 Obstetrics & Gynecology doctors found. Showing 1 - 5

Jodi Schulz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-373-2384

Joseph Mario Lombardi, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-373-2384

Dr. Caitlin Dunham, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-377-6285

Richard E Mayerchak, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-373-2384

Heidi Jo Gaston, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-377-6798    Fax: 507-377-6765

News Archive

Early-life exposure to PCBs diminishes immune response to diphtheria and tetanus vaccinations: Study

Children exposed to polychlorinated biphenyls early in life later had a diminished immune response to diphtheria and tetanus vaccinations, according to a study published online June 20 ahead of print in the peer-reviewed journal Environmental Health Perspectives. This result suggests that PCB exposure during the first years of life, a critical period in immune system development, could undermine the effectiveness of childhood vaccinations and possibly impair immune system responses to infection.

CASI receives CFDA approval for ENMD-2076 Phase 2 clinical trial in ovarian clear cell carcinoma

CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announced today that the China Food and Drug Administration (CFDA) has approved the Company's application to conduct a Phase 2 global clinical trial in ovarian clear cell carcinoma (OCCC) patients for its proprietary drug candidate ENMD-2076.

Mindray launches new DP-50 ultrasound system

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, today announced the introduction of the company's new DP-50 ultrasound system in the United States. The black and white portable unit provides outstanding imaging quality in a compact system and is designed for use in numerous specialty markets.

‘Zero pressure' mattress solutions to be showcased at MEDICA 2015

‘Stop the Pressure' is the message from pressure ulcer specialist Rober, who is showcasing their wide range of innovative mattresses in support of Worldwide STOP Pressure Ulcer Day at MEDICA 2015, the world's largest healthcare technology exhibition.

NIH, NanoBio sign licensing agreement to develop vaccine against RSV infections

NanoBio Corporation today announced a licensing agreement with the National Institutes of Health (NIH) that represents a significant step forward in developing the first vaccine to protect against respiratory syncytial virus (RSV) infections.

Read more Medical News

› Verified 1 days ago